Reviewing CollPlant Biotechnologies (NASDAQ:CLGN) and LogicMark (NASDAQ:LGMK)

CollPlant Biotechnologies (NASDAQ:CLGNGet Rating) and LogicMark (NASDAQ:LGMKGet Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability and risk.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for CollPlant Biotechnologies and LogicMark, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CollPlant Biotechnologies 0 0 0 0 N/A
LogicMark 0 0 0 0 N/A

Valuation & Earnings

This table compares CollPlant Biotechnologies and LogicMark’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
CollPlant Biotechnologies $15.64 million 3.62 $240,000.00 ($1.34) -3.81
LogicMark $10.02 million 0.64 -$11.71 million N/A N/A

CollPlant Biotechnologies has higher revenue and earnings than LogicMark.

Insider and Institutional Ownership

0.2% of CollPlant Biotechnologies shares are owned by institutional investors. Comparatively, 9.6% of LogicMark shares are owned by institutional investors. 9.6% of CollPlant Biotechnologies shares are owned by insiders. Comparatively, 8.5% of LogicMark shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.


This table compares CollPlant Biotechnologies and LogicMark’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CollPlant Biotechnologies -2,576.29% -34.02% -30.29%
LogicMark -88.42% -43.92% -37.13%


CollPlant Biotechnologies beats LogicMark on 6 of the 8 factors compared between the two stocks.

About CollPlant Biotechnologies

(Get Rating)

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.

About LogicMark

(Get Rating)

LogicMark, Inc. offers personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company, through its subsidiary, LogicMark LLC, manufactures and distributes non-monitored and monitored personal emergency response systems sold through healthcare durable medical equipment and monitored security dealers/distributors, and the United States Department of Veterans Affairs. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.

Receive News & Ratings for CollPlant Biotechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CollPlant Biotechnologies and related companies with's FREE daily email newsletter.